Cite
MLA Citation
Kyriaki Tzogani et al.. “European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.” ESMO open, vol. 4, no. 5, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100127573410.0x00001e